China’s military firms struggle as corruption purge bites, report says

SIPRI analysis shows revenues at China’s top military firms fell 10% in 2024, driven by corruption-related procurement reviews and cancelled or postponed contracts; Norinco saw the steepest drop, down 31% to $14 billion, while AVIC and CASC also slowed. By contrast, global arms revenues rose 5.9% to a record $679 billion with Japan up 40%, Germany 36% and the US up 3.8%, highlighting a regional divergence that injects near-term uncertainty into Beijing’s military modernisation timelines even as defence budgets and long-term investment commitments remain elevated.

Analysis

Market structure: SIPRI’s data (China top arms revenues -10% vs Japan +40%, Germany +36%, US +3.8%) signals a near-term reallocation of procurement and program execution away from Chinese state champions into non-Chinese suppliers. Winners are Western and Japanese prime contractors (scale, exportable tech); losers are Chinese state-owned system integrators (AVIC, Norinco, CASC) and their domestic supply chains where projects face review and cancellations. The shift should increase pricing power and order visibility for OEMs in the US/EU/JP for 6–24 months while compressing margins and cash conversion for affected Chinese suppliers.

Risk assessment: Tail risks include an intensified political purge that freezes Beijing procurement for 12+ months (high impact on China defense SOE cashflows) or a rapid political reversion that restarts awards (fast recovery). Immediate (days) risk is sentiment-driven equity weakness in China industrials; short-term (weeks–months) is contract delays and working capital stress at suppliers; long-term (quarters–years) is accelerated Western market share gains but higher overall program unit costs globally. Hidden dependencies: Chinese SOE liquidity is tied to state guarantees—contagion to provincial banks or SOE bond spreads could appear within 3–6 months if defaults emerge.

Trade implications: Tactical overweight defense equity exposure in US/Japan/EU (expect incremental revenue reallocation of ~5–15% for primes over 12 months) and tactical underweight Chinese defense-linked equities/FTSE China large caps. Use ETF and blue‑chip plays to capture this trade while avoiding illiquid Chinese names. Cross-asset: expect mild CNY weakness (-1–3%) on risk premium and modest widening of Chinese SOE CDS spreads.

Contrarian angles: Consensus underestimates Chinese political capacity to backstop strategic suppliers—state recapitalizations could appear within 3–9 months, creating a snap-back rally in beaten-down names. The market may be over-discounting permanent capability loss; technology transfer and international orders will sustain global primes, but domestic Chinese modernization remains a multi-year program likely to resume, creating mean-reversion setups in select China industrials.

Key Decisions for Investors

• Establish a 2–3% portfolio long in ITA (iShares US Aerospace & Defense ETF) and split equally into 6–12 month call spreads on LMT (Lockheed Martin) and NOC (Northrop Grumman): buy 12‑month ATM+10% calls and sell 12‑month ATM+25% calls to cap cost; target 15–30% upside, stop-loss at -12%.
• Reduce China industrial/defense exposure by 2–4%: implement a 3–6 month put spread on FXI (iShares China Large‑Cap ETF) sized to offset existing China cyclical exposure (buy 3‑month 5% OTM puts, sell 3‑month 2% OTM puts) to hedge downside from further procurement delays or SOE credit stress.
• Initiate a 1–2% long position in 7011.T (Mitsubishi Heavy Industries) or EWJ (iShares MSCI Japan ETF) to capture Japan’s reported +40% revenue tailwind; hold 6–18 months and trim into any >20% rally.
• Buy protection / raise cash if Chinese SOE 5‑year CDS widens +50bp from current levels or if Norinco/CASC confirmed revenue misses exceed -20% QoQ; if triggered within 90 days, reduce China equities by an additional 3–5%.
• Monitor three catalysts over next 30–90 days before scaling: (1) official procurement re-notifications or cancellations (threshold: >$5bn cumulative delayed awards), (2) Chinese SOE bond spread widening >40bp, (3) public sanctions or export-licensing changes by US/EU — act to increase defense longs if cascade delays persist, or rotate back into China SOEs if state recapitalization announced.